ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies develop #vaccines in the infectious diseases and oncology fields. We apply unique technologies for protein production (the Drosophila S2 platform, ExpreS2) and improved immunogenicity (the capsid virus-like particle (cVLP) platform). Preclinical- and clinical-stage product candidates against #Covid-19, #breastcancer, #malaria, & #flu. Use  http://expres2ionbio.com/contact/ for Q&A.